Kira Pharmaceuticals is a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases. Enabled by its proprietary LOGIC drug discovery platform, Kira is committed to advancing first-in-class and best-in-class therapies to patients around the world. The company is headquartered in Cambridge, Massachusetts with an R&D center in Suzhou, China.